Results 221 to 230 of about 365,495 (322)

Imidazolinium-Based NHC-Metal Complexes Overcome Both Cancer Multidrug Resistance and Cisplatin Resistance In Vitro. [PDF]

open access: yesInt J Mol Sci
Szlávik M   +8 more
europepmc   +1 more source

Microarray analysis of gene expression profile of multidrug resistance in pancreatic cancer

open access: gold, 2007
Yupei Zhao   +5 more
openalex   +1 more source

Antimicrobial Cyclic Peptidomimetics

open access: yesMacromolecular Rapid Communications, EarlyView.
Singular macromolecular cationic, amphipathic cyclic peptidomimetics with poly(2‐oxazoline)s‐esque backbone structure that undergo self‐assembly in water to form uniform nanoparticles were developed. The cyclic peptidomimetics, which act on bacterial cell membranes, exhibit hydrophobic‐dependent antimicrobial activity and toxicity.
Hao Luo, Edgar H. H. Wong
wiley   +1 more source

Targeting NFAT2 for Reversing the P-gp-Mediated Multidrug Resistance to Paclitaxel by Manidipine. [PDF]

open access: yesCancers (Basel)
Zhou J   +8 more
europepmc   +1 more source

Multidrug resistance-associated protein 1 and lung function decline with or without long-term corticosteroids treatment in COPD

open access: green, 2012
Simona E. Budulac   +8 more
openalex   +2 more sources

Uncovering Key Characteristics of Antibacterial Peptides through Machine Learning

open access: yesMacromolecular Rapid Communications, EarlyView.
Machine‐learning (ML) techniques using random forest classification models revealed key characteristics that predict effective antimicrobial peptides (AMPs) targeting Gram‐negative bacteria, Gram‐positive bacteria, and mycobacteria. The ideal cLogP (<$ < $−6) and net‐charge (≤+4) threshold was the same for all three targets with variations in the ...
Jooyoung Roh   +2 more
wiley   +1 more source

Suppressing protein damage response to overcome multidrug resistance in cancer therapy. [PDF]

open access: yesCell Discov
Shao F   +25 more
europepmc   +1 more source

Machine Learning for Predictive Modeling in Nanomedicine‐Based Cancer Drug Delivery

open access: yesMed Research, EarlyView.
The integration of AI/ML into nanomedicine offers a transformative approach to therapeutic design and optimization. Unlike conventional empirical methods, AI/ML models (such as classification, regression, and neural networks) enable the analysis of complex clinical and formulation datasets to predict optimal nanoparticle characteristics and therapeutic
Rohan Chand Sahu   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy